BIOFORCE NANOSCIENCES HOLDINGS, INC.
No SEC Form 4 filings for $BFNH in the last 30 days.
See all $BFNH insider activity →BioForce Nanosciences Holdings, Inc. (BFNH) acquired 100% leasehold in two Texas leases totaling 67.59 acres and is evaluating the Herrin-1 site, which has 23.5 Bcf of gross proved developed behind-pipe gas. Reactivation of Herrin-1 could cost $2.5M+.
BioForce Nanosciences Holdings, Inc. (OTC: BFNH) has expanded its oil and gas portfolio with two Texas leases totaling 67.59 acres. The Herrin-1 well, with estimated reserves of 285,730 barrels of oil and 23.5 billion cubic feet of natural gas, requires at least $2.5 million for assessment and potential restart. BFNH is conducting a feasibility analysis but has not finalized any plans.
BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH) filed an SEC Form 8-K — Unregistered Sales of Equity Securities. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 31, 2026 BIOFORCE NANOSCIENCES HOLDINGS, INC. (Exact name of registran
Over the past 7 days, AlphAI's AI scored 2 news stories mentioning BFNH (BIOFORCE NANOSCIENCES HOLDINGS, INC.). Coverage has skewed bearish: 0 bullish, 1 neutral, and 1 bearish.
Recent BFNH coverage spans financial news, corporate actions and insider activity.
The lease acquisition could become a near‑term revenue catalyst if financing is secured and Herrin‑1 is restarted, but the $2.5M restart cost creates short‑term pressure.
The disclosed cost and uncertainty may weigh on BFNH's near‑term valuation.
The unregistered equity sale dilutes existing shareholders but raises modest capital for the company.
Significant insider sell may signal lack of confidence, potential short-term pressure on stock.
BLM approval and planned exploration are a near-term catalyst for BFNH, but economics remain unconfirmed pending technical work.
AlphAI scores every news story that mentions BFNH with an AI model for sentiment and relevance, and aggregates insider trades from BIOFORCE NANOSCIENCES HOLDINGS, INC.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
BioForce Nanosciences Holdings, Inc. (BFNH) acquired 100% leasehold in two Texas leases totaling 67.59 acres and is evaluating the Herrin-1 site, which has 23.5 Bcf of gross proved developed behind-pipe gas. Reactivation of Herrin-1 could cost $2.5M+.
1 min readBioForce Nanosciences Holdings, Inc. (OTC: BFNH) has expanded its oil and gas portfolio with two Texas leases totaling 67.59 acres. The Herrin-1 well, with estimated reserves of 285,730 barrels of oil and 23.5 billion cubic feet of natural gas, requires at least $2.5 million for assessment and potential restart. BFNH is conducting a feasibility analysis but has not finalized any plans.
2 min readBIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH) filed an SEC Form 8-K — Unregistered Sales of Equity Securities. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 31, 2026 BIOFORCE NANOSCIENCES HOLDINGS, INC. (Exact name of registran
1 min readFerguson Merle sold 26,700,000 shares of BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH) at $0.02 ($0.40M total) on 2026-04-22.
1 min readBioforce Nanosciences Holdings (OTC: BFNH) said the U.S. Bureau of Land Management approved assignment of 11 federal oil and gas leases in Nevada’s White River Valley covering about 20,000 acres. The company plans exploration and development, including possible 3D seismic and drilling. Ryder Scott was hired on June 26, 2026 to estimate resources and NPV.
3 min readBIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. false 0001310488 0001310488 2026-04-15 2026-04-15 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Repor
4 min read
